기본 통계
| LEI | 254900XU539S8GOIOW89 |
| CIK | 1729149 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Viemed Healthcare, Inc.
SEC Filings (Chronological Order)
이 페이지는 다른 곳에서 제공하는 소유권 보고서를 제외한 SEC 보고서의 전체 리스트를 시간 순으로 정리한 것입니다.
| June 4, 2026 |
SECOND AMENDMENT VIEMED HEALTHCARE, INC. 2024 LONG TERM INCENTIVE PLAN (Effective June 6, 2024) SECOND AMENDMENT VIEMED HEALTHCARE, INC. 2024 LONG TERM INCENTIVE PLAN (Effective June 6, 2024) The Viemed Healthcare, Inc. 2024 Long Term Incentive Plan ( as previously amended, the “Plan”) is hereby amended, effective June 4, 2026, if approved by the Company’s shareholders at the annual general and special meeting of shareholders on June 4, 2026, for Awards granted after the effective date as fo |
|
| June 4, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 4, 2026 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| June 2, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 2, 2026 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| June 2, 2026 |
a2026-06viemedinvestorde A Rapidly Growing National Leader In Home-Based Clinical Care. |
|
| May 5, 2026 |
viemedq12026supplementa 1 Financial Supplement First Quarter 2026 May 5, 2026 NASDAQ: VMD Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U. |
|
| May 5, 2026 |
VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS Lafayette, Louisiana (May 5, 2026) Viemed Healthcare, Inc. |
|
| May 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2026 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| May 5, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 5, 2026 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| April 22, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State |
|
| April 22, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 22, 2026 | ||
| March 16, 2026 |
march2026investordeck A Rapidly Growing National Leader In Home-Based Clinical Care. |
|
| March 16, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 16, 2026 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| March 4, 2026 |
RESTRICTED STOCK UNITS AWARD AGREEMENT RESTRICTED STOCK UNITS AWARD AGREEMENT (DIRECTOR) THIS RESTRICTED STOCK UNITS AWARD AGREEMENT (this “Agreement”) is made and entered into by and between Viemed Healthcare, Inc. |
|
| March 4, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2026 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 4, 2026 |
VIEMED HEALTHCARE ANNOUNCES 2026 SHARE REPURCHASE PROGRAM VIEMED HEALTHCARE ANNOUNCES 2026 SHARE REPURCHASE PROGRAM LAFAYETTE, La., (March 4, 2026) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ: VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, today announced that its Board of Directors has authorized a share repurchase program effective through March 2027. Under the share repu |
|
| March 4, 2026 |
viemedq42025supplementa Financial Supplement NASDAQ: VMD March 4, 2026 1 Fourth Quarter & Full Year 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U. |
|
| March 4, 2026 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| March 4, 2026 |
EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, LLC Louisiana Viemed Healthcare Staffing, LLC Louisiana Viemed Real Estate Holdings, LLC Louisiana Home Medical Products, Inc. Tennessee Schofield Homecare Services, Inc. Alabama Spirocare DME, LLC Tennessee East |
|
| March 4, 2026 |
VIEMED HEALTHCARE ANNOUNCES RECORD 2025 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2025 FINANCIAL RESULTS Lafayette, Louisiana (March 4, 2026) Viemed Healthcare, Inc. |
|
| March 4, 2026 |
RESTRICTED STOCK UNITS AWARD AGREEMENT RESTRICTED STOCK UNITS AWARD AGREEMENT (EMPLOYEE) THIS RESTRICTED STOCK UNITS AWARD AGREEMENT (this “Agreement”) is made and entered into by and between Viemed Healthcare, Inc. |
|
| November 7, 2025 |
q32025xinvestorxpresent Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD November 2025 VieMed Healthcare Inc. |
|
| November 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 7, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 7, 2025 |
THIRD AMENDMENT THIS THIRD AMENDMENT (this “Amendment”) dated as of November 7, 2025 to the Credit Agreement referenced below is by and among VIEMED, INC. |
|
| November 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, |
|
| November 5, 2025 |
viemedq32025supplementa Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care November 5, 2025 1 Third Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U. |
|
| November 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 5, 2025 |
VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS Lafayette, Louisiana (November 5, 2025) Viemed Healthcare, Inc. |
|
| September 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) |
|
| September 23, 2025 |
VIEMED HEALTHCARE ANNOUNCES COMPLETION OF SHARE REPURCHASE PROGRAM VIEMED HEALTHCARE ANNOUNCES COMPLETION OF SHARE REPURCHASE PROGRAM LAFAYETTE, La., (September 23, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that it has completed all repurchases authorized under its previously announced share repurchase program. On June 9, 2025, the Company a |
|
| August 12, 2025 |
As filed with the Securities and Exchange Commission on August 12, 2025. As filed with the Securities and Exchange Commission on August 12, 2025. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VIEMED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) British Columbia, Canada N/A (State or Other Jurisdiction of Incorporation or Organizatio |
|
| August 12, 2025 |
Table 1: Newly Registered Securities Calculation of Filing Fee Tables S-8 VIEMED HEALTHCARE, INC. Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee 1 Equity Common shares, no par value Other 412,351 $ 6.90 $ 2,845,221.90 0.0001531 $ 435.60 Total Offering Amounts: $ |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| August 6, 2025 |
VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS Lafayette, Louisiana (August 6, 2025) Viemed Healthcare, Inc. |
|
| August 6, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| August 6, 2025 |
viemedq22025supplementa Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care August 6, 2025 1 Second Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U. |
|
| July 2, 2025 |
VIEMED COMPLETES ACQUISITION OF LEHAN’S MEDICAL EQUIPMENT ANTICIPATES UPDATING ITS FULL YEAR 2025 OUTLOOK FOR THE ACQUISITION WITH SECOND QUARTER 2025 FINANCIAL RESULTS LAFAYETTE, Louisiana (July 2, 2025) Viemed Healthcare, Inc. |
|
| July 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 2, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| June 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| June 9, 2025 |
VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM LAFAYETTE, La., (June 9, 2025) Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader of in-home, technology-enabled post-acute respiratory care, today announced that its Board of Directors has authorized a share repurchase program, effective through June 2026. Under the share repurchase program, Viemed may purchase |
|
| June 9, 2025 |
SECOND AMENDMENT THIS SECOND AMENDMENT (this “Amendment”) dated as of June 6, 2025 to the Credit Agreement referenced below is by and among VIEMED, INC. |
|
| June 9, 2025 |
Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD June 2025 VieMed Healthcare Inc. |
|
| June 5, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 5, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| June 5, 2025 |
Amendment to the 2024 Long Term Incentive Plan, effective June 5, 2025 FIRST AMENDMENT VIEMED HEALTHCARE, INC. 2024 LONG TERM INCENTIVE PLAN (Effective June 6, 2024) The Viemed Healthcare, Inc. 2024 Long Term Incentive Plan (the “Plan”) is hereby amended, effective June 5, 2025, if approved by the Company’s shareholders at the annual general and special meeting of shareholders on June 5, 2025, for Awards granted after the effective date as follows: 1. The first sente |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| May 7, 2025 |
Executive Employment Agreement dated effective June 3, 2019 by EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the “Agreement) is entered into effective June 3, 2019 (the “Effective Date”), by and between Trae P. |
|
| May 7, 2025 |
VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS LAFAYETTE, Louisiana (May 7, 2025) Viemed Healthcare, Inc. |
|
| May 7, 2025 |
Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care May 7, 2025 1 First Quarter 2025 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U. |
|
| May 7, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 7, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 7, 2025 |
Executive Employment Agreement dated effective EXECUTIVE EMPLOYMENT AGREEMENT This EXECUTIVE EMPLOYMENT AGREEMENT (the "Agreement”) is entered into effective August 1, 2022 (the "'Effective Date”), by and between Jeremy Trahan (the "Executive”) and Sleep Management. |
|
| May 6, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 6, 2025 |
VIEMED EXECUTES DIVERSIFICATION STRATEGY WITH $26 MILLION ACQUISITION OF HOME EQUIPMENT PROVIDER IN ILLINOIS LAFAYETTE, Louisiana (May 6, 2025) Viemed Healthcare, Inc. |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State |
|
| April 25, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| April 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 14, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| March 18, 2025 |
Leading the Healthcare Industry in Home Respiratory Care Investor Presentation: NASDAQ: VMD March 2025 VieMed Healthcare Inc. |
|
| March 18, 2025 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 18, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| March 10, 2025 |
Subsidiaries of the Registrant. EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, LLC Louisiana Viemed Healthcare Staffing, LLC Louisiana Viemed Real Estate Holdings, LLC Louisiana Home Medical Products, Inc. Tennessee Schofield Homecare Services, Inc. Alabama Spirocare DME, LLC Tennessee East |
|
| March 10, 2025 |
VIEMED HEALTHCARE ANNOUNCES RECORD 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2024 FINANCIAL RESULTS Lafayette, Louisiana (March 10, 2025) Viemed Healthcare, Inc. |
|
| March 10, 2025 |
VIEMED HEALTHCARE, INC. INSIDER TRADING POLICY DATED: JANUARY 21, 2025 PURPOSE OF THIS POLICY The purpose of this insider trading policy (the “Policy”) of VieMed Healthcare, Inc. (the “Company”) is to provide guidelines with respect to transactions in Company Securities and the handling of confidential information about the Company and any Subsidiary and the companies with which the Company or any |
|
| March 10, 2025 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 10, 2025 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| March 10, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| March 10, 2025 |
Financial Supplement NASDAQ: VMD Leading th e Healthcare Industry in Home Respiratory Care March 10, 2025 1 Fourth Quarter & Full Year 2024 Disclaimers Forward Looking Statements Certain statements contained in this Financial Supplement may constitute “forward-looking statements” within the meaning of the U. |
|
| November 12, 2024 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD November 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. |
|
| November 12, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 12, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 8, 2024 |
VMD / Viemed Healthcare, Inc. / BlackRock, Inc. Passive Investment SC 13G/A 1 ca92663r1055110824.txt ca92663r1055110824.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) BFFK5Z9 - (SEDOL Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| November 6, 2024 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 6, 2024 |
VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS Lafayette, Louisiana (November 6, 2024) Viemed Healthcare, Inc. |
|
| November 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, |
|
| October 22, 2024 |
VMD / Viemed Healthcare, Inc. / BlackRock, Inc. Passive Investment SC 13G/A 1 ca92663r1055102224.txt ca92663r1055102224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) BFFK5Z9 - (SEDOL Number) September 30, 2024 - (Date of Event Which Requires Filing of this Statement) Check the appropriate |
|
| August 14, 2024 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD August 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. |
|
| August 14, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 14, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| August 12, 2024 |
As filed with the Securities and Exchange Commission on August 12, 2024. As filed with the Securities and Exchange Commission on August 12, 2024. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 VIEMED HEALTHCARE, INC. (Exact name of registrant as specified in its charter) British Columbia, Canada N/A (State or Other Jurisdiction of Incorporation or Organizatio |
|
| August 12, 2024 |
Calculation of Filing Fee Tables Exhibit 107.1 Calculation of Filing Fee Tables Form S-8 (Form Type) Viemed Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common shares, no par val |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 7, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| August 7, 2024 |
VIEMED HEALTHCARE ANNOUNCES RECORD SECOND QUARTER 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD SECOND QUARTER 2024 FINANCIAL RESULTS Lafayette, Louisiana (August 7, 2024) Viemed Healthcare, Inc. |
|
| August 7, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| June 6, 2024 | ||
| June 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| May 29, 2024 | ||
| May 29, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 28, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 9, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 9, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commis |
|
| May 9, 2024 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD May 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 6, 2024 |
VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS Lafayette, Louisiana (May 6, 2024) Viemed Healthcare, Inc. |
|
| May 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State |
|
| April 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| April 2, 2024 |
VIEMED ANNOUNCES ACQUISITION OF MAJORITY INTEREST IN HOMEMED, FORGING PARTNERSHIP WITH EAST ALABAMA HEALTH Lafayette, Louisiana (April 2, 2024) Viemed Healthcare, Inc. |
|
| April 2, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 April 2, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| March 11, 2024 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD March 2024 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. |
|
| March 11, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 March 11, 2024 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 6, 2024 |
Subsidiaries of the Registrant. EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, LLC Louisiana Viemed Healthcare Staffing, LLC Louisiana Viemed Real Estate Holdings, LLC Louisiana Home Medical Products, Inc. Tennessee Schofield Homecare Services, Inc. Alabama Spirocare DME, LLC Tennessee 1 |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 6, 2024 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 6, 2024 |
Viemed Healthcare, Inc. Executive Compensation Clawback Policy, as adopted on November 9, 2023. Exhibit 97.1 VIEMED HEALTHCARE, INC. EXECUTIVE COMPENSATION CLAWBACK POLICY 1.OVERVIEW In accordance with the applicable rules of The Nasdaq Stock Market (the “Nasdaq Rules”), Section 10D and Rule 10D-1 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”) (“Rule 10D-1”), the Board of Directors (the “Board”) of Viemed Healthcare, Inc. (the “Company”) has adopted this Policy (the |
|
| March 6, 2024 |
VIEMED HEALTHCARE ANNOUNCES RECORD 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2023 FINANCIAL RESULTS Lafayette, Louisiana (March 6, 2024) Viemed Healthcare, Inc. |
|
| March 6, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| March 6, 2024 |
Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc. |
|
| February 15, 2024 |
VMD / Viemed Healthcare, Inc. / Hoyt Casey - SC 13G/A Passive Investment SC 13G/A 1 sc13gachoyt-2152024.htm SC 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 4)1 Viemed Healthcare, Inc. (Name of Issuer) Common Shares, No Par Value (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box t |
|
| February 15, 2024 |
VMD / Viemed Healthcare, Inc. / Moore Michael - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240. |
|
| February 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* Viemed Healthcare, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 92840H400 (CUSIP Number) December 31, 2023 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| February 13, 2024 |
VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment SC 13G/A 1 tfl13ga3viemed.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 3 )* Viemed Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th |
|
| February 2, 2024 |
VMD / Viemed Healthcare, Inc. / BlackRock Inc. Passive Investment SC 13G 1 ca92663r1055020224.txt ca92663r1055020224.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) BFFK5Z9 - (SEDOL Number) December 31, 2023 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box |
|
| December 7, 2023 |
VIEMED TO CENTRALIZE MARKET FOR COMMON SHARES ON NASDAQ THROUGH VOLUNTARY DELISTING FROM TSX VIEMED TO CENTRALIZE MARKET FOR COMMON SHARES ON NASDAQ THROUGH VOLUNTARY DELISTING FROM TSX Lafayette, Louisiana (December 7, 2023) Viemed Healthcare, Inc. |
|
| December 7, 2023 |
Regulation FD Disclosure, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 December 7, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| November 8, 2023 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD. |
|
| November 8, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 7, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| November 1, 2023 |
VIEMED HEALTHCARE ANNOUNCES RECORD THIRD QUARTER 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD THIRD QUARTER 2023 FINANCIAL RESULTS Lafayette, Louisiana (November 1, 2023) Viemed Healthcare, Inc. |
|
| November 1, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, |
|
| August 31, 2023 |
United States securities and exchange commission logo August 31, 2023 Trae Fitzgerald Chief Financial Officer Viemed Healthcare, Inc. |
|
| August 31, 2023 |
August 31, 2023 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Mr. Nicholas O’Leary Re: Viemed Healthcare, Inc. Registration Statement on Form S-3 Filed August 24, 2023 File No. 333-274198 Dear Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended, Viemed Healthcare, Inc. (the |
|
| August 24, 2023 |
As filed with the Securities and Exchange Commission on August 24, 2023 TABLE OF CONTENTS As filed with the Securities and Exchange Commission on August 24, 2023 Registration No. |
|
| August 24, 2023 |
Exhibit 107 Calculation of Filing Fee Tables S-3 (Form Type) Viemed Healthcare, Inc. |
|
| August 10, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 10, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| August 10, 2023 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD. |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| August 9, 2023 |
VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2023 FINANCIAL RESULTS Lafayette, Louisiana (August 9, 2023) Viemed Healthcare, Inc. |
|
| August 9, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| August 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 2, 2023 (June 1, 2023) Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other |
|
| August 2, 2023 |
HOME MEDICAL PRODUCTS, INC. AND SUBSIDIARY Jackson, Tennessee Consolidated Financial Statements Year Ended December 31, 2022 CONTENTS Independent Auditor's Report 1 – 2 Consolidated Financial Statements Consolidated Balance Sheet 3 Consolidated Statement of Income 4 Consolidated Statement of Shareholder's Equity 5 Consolidated Statement of Cash Flows 6 Notes to Consolidated Financial Statements 7 |
|
| August 2, 2023 |
UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION The following unaudited pro forma condensed combined financial statements combine the separate historical financial information of Viemed Healthcare, Inc. |
|
| August 2, 2023 |
HOME MEDICAL PRODUCTS, INC. Jackson, Tennessee Financial Statements Three Months Ended March 31, 2023 CONTENTS Financial Statements Balance Sheet 1 Statement of Income 2 Statement of Shareholder's Equity 3 Statement of Cash Flows 4 Notes to Financial Statements 5 – 14 HOME MEDICAL PRODUCTS, INC. Balance Sheet March 31, 2023 2023 ASSETS Current assets Cash and cash equivalents $ 310,636 Certificate |
|
| June 13, 2023 |
VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS Lafayette, Louisiana (June 13, 2023) Viemed Healthcare, Inc. |
|
| June 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 13, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| June 1, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 June 1, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| June 1, 2023 |
VIEMED ANNOUNCES SUCCESSFUL COMPLETION OF HMP ACQUISITION VIEMED ANNOUNCES SUCCESSFUL COMPLETION OF HMP ACQUISITION Lafayette, Louisiana (June 1, 2023) Viemed Healthcare, Inc. |
|
| May 18, 2023 |
VMD / Viemed Healthcare Inc / Moore Michael - SC 13D/A Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240. |
|
| May 9, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 May 9, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commis |
|
| May 9, 2023 |
investorpresentationmay2 Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD. |
|
| May 8, 2023 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 8, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 8, 2023 |
VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS Lafayette, Louisiana (May 8, 2023) Viemed Healthcare, Inc. |
|
| May 8, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State |
|
| April 19, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 April 18, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| April 19, 2023 |
STOCK PURCHASE AGREEMENT BY AND AMONG VIEMED, INC., HOME MEDICAL PRODUCTS, INC., KEVIN ATKINS, individually, as an Equityholder, DAVID STEELE, individually, as an Equityholder, and DAVID STEELE, as the Equityholders’ Representative Dated as of April 18, 2023 TABLE OF CONTENTS Page ARTICLE I SALE AND PURCHASE OF EQUITY 1 1.1. Sale and Purchase of Equity 1 1.2. Purchase Price 2 1.3. Adjustment Amoun |
|
| April 19, 2023 |
VIEMED ACCELERATES GROWTH THROUGH ACQUISITION OF TENNESSEE BASED HOME MEDICAL PRODUCTS, INC. VIEMED ACCELERATES GROWTH THROUGH ACQUISITION OF TENNESSEE BASED HOME MEDICAL PRODUCTS, INC. |
|
| March 3, 2023 |
investorpresentationmarc Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD. |
|
| March 3, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 March 3, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| March 2, 2023 |
VIEMED HEALTHCARE ANNOUNCES 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES 2022 FINANCIAL RESULTS Lafayette, Louisiana (March 2, 2023) Viemed Healthcare, Inc. |
|
| March 2, 2023 |
Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc. |
|
| March 2, 2023 |
Subsidiaries of the Registrant. EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, L.L.C. Louisiana Viemed Healthcare Staffing, L.L.C. Louisiana 1 |
|
| March 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 2, 2023 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| February 21, 2023 |
VMD / Viemed Healthcare Inc / VIEMED HEALTHCARE, INC. - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 8, 2023 |
VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment SC 13G/A 1 tfl13gviemed.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* Viemed Healthcare, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the |
|
| January 23, 2023 |
VIEMED WINS COMPLETE OVERRULING OF APPEALED OIG CLAIMS RESOLVING MULTIYEAR PROCESS WITH HHS AND CMS VIEMED WINS COMPLETE OVERRULING OF APPEALED OIG CLAIMS RESOLVING MULTIYEAR PROCESS WITH HHS AND CMS Lafayette, Louisiana (January 23, 2023) Viemed Healthcare, Inc. |
|
| January 23, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 January 23, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| January 12, 2023 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 January 12, 2023 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| January 12, 2023 |
VIEMED ANNOUNCES STRATEGIC INVESTMENT IN POPULATION HEALTH SECTOR VIEMED ANNOUNCES STRATEGIC INVESTMENT IN POPULATION HEALTH SECTOR Lafayette, Louisiana (January 12, 2023) Viemed Healthcare, Inc. |
|
| November 29, 2022 |
PLEDGE AND SECURITY AGREEMENT THIS PLEDGE AND SECURITY AGREEMENT (this ?Agreement?) is entered into as of November 29, 2022 among the parties identified as ?Obligors? on the signature pages hereto and such other parties that may become Obligors hereunder after the date hereof (each, an ?Obligor? and collectively, the ?Obligors?), and Regions Bank, in its capacity as collateral agent (in such capacity, the ?Collateral Agent?) for the holders of the Obligations. |
|
| November 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 29, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 29, 2022 |
CREDIT AGREEMENT dated as of November 29, 2022 among VIEMED, INC., as Borrower, CERTAIN SUBSIDIARIES OF THE BORROWER PARTY HERETO FROM TIME TO TIME, as Guarantors, THE LENDERS PARTY HERETO, and REGIONS BANK, as Administrative Agent and Collateral Agent REGIONS CAPITAL MARKETS, a division of Regions Bank, as Sole Lead Arranger and Sole Bookrunner TABLE OF CONTENTS Page Section 1. DEFINITIONS AND IN |
|
| November 29, 2022 |
VIEMED ANNOUNCES NEW SENIOR SECURED CREDIT FACILITIES VIEMED ANNOUNCES NEW SENIOR SECURED CREDIT FACILITIES Lafayette, Louisiana (November 29, 2022) Viemed Healthcare, Inc. |
|
| November 3, 2022 |
Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD. |
|
| November 3, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 3, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| November 1, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, |
|
| November 1, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 1, 2022 |
VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2022 FINANCIAL RESULTS Lafayette, Louisiana (November 1, 2022) Viemed Healthcare, Inc. |
|
| October 18, 2022 |
VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| August 5, 2022 |
investorpresenationaugus Investor Presentation Leading the Healthcare Industry in Home Respiratory Care NASDAQ: VMD TSX: VMD. |
|
| August 5, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 4, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| August 2, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| August 2, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| August 2, 2022 |
VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2022 FINANCIAL RESULTS Lafayette, Louisiana (August 2, 2022) Viemed Healthcare, Inc. |
|
| August 1, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 1, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| August 1, 2022 |
VIEMED ANNOUNCES EXECUTIVE ADDITIONS TO LEAD ACQUISITION GROWTH VIEMED ANNOUNCES EXECUTIVE ADDITIONS TO LEAD ACQUISITION GROWTH Lafayette, Louisiana (August 1, 2022) Viemed Healthcare, Inc. |
|
| July 8, 2022 |
CA:VMD / Viemed Healthcare Inc / BlackRock Inc. Passive Investment ca92663r1055070822.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) BFFK5Z9 - (SEDOL Number) June 30, 2022 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to w |
|
| July 5, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 July 5, 2022 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| July 5, 2022 |
VIEMED ANNOUNCES PUBLICATION OF PEER-REVIEWED NIVH STUDY FINDING TREATMENT REDUCES HEALTHCARE COSTS AND SAVES LIVES Lafayette, Louisiana (July 5, 2022) Viemed Healthcare, Inc. |
|
| June 28, 2022 |
CA:VMD / Viemed Healthcare Inc / Cove Street Capital, LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 92663r105 (CUSIP Number) Merihan Tynan 2101 East El Segundo Boulevard. Suite 302 El Segundo, CA 90245 (Name, Address and Telephone Number of Person Author |
|
| June 9, 2022 |
VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING OF SHAREHOLDERS Lafayette, Louisiana (June 9, 2022) Viemed Healthcare, Inc. |
|
| June 9, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 9, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| May 16, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 16, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| May 16, 2022 |
VIEMED PROVIDES UPDATE CONCERNING SUCCESSFUL APPEAL OF OFFICE OF INSPECTOR GENERAL FINDINGS VIEMED PROVIDES UPDATE CONCERNING SUCCESSFUL APPEAL OF OFFICE OF INSPECTOR GENERAL FINDINGS Lafayette, Louisiana (May 16, 2022) Viemed Healthcare, Inc. |
|
| May 4, 2022 |
LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2022 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about VieMed Healthcare, Inc. |
|
| May 4, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 3, 2022 |
VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2022 FINANCIAL RESULTS Lafayette, Louisiana (May 3, 2022) Viemed Healthcare, Inc. |
|
| May 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| May 3, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| April 29, 2022 |
DEF 14A 1 a2022def14aproxydoc.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by |
|
| April 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 14, 2022 |
CA:VMD / Viemed Healthcare Inc / Cove Street Capital, LLC Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. -)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares, no par value (Title of Class of Securities) 92663r105 (CUSIP Number) Merihan Tynan 2101 East El Segundo Boulevard. Suite 302 El Segundo, CA 90245 (Name, Address and Telephone Number of |
|
| March 8, 2022 |
VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM VIEMED HEALTHCARE ANNOUNCES SHARE REPURCHASE PROGRAM Lafayette, Louisiana (March 8, 2022) Viemed Healthcare, Inc. |
|
| March 8, 2022 |
LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MARCH 2022 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about VieMed Healthcare, Inc. |
|
| March 8, 2022 |
Regulation FD Disclosure, Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 7, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| March 7, 2022 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 7, 2022 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 7, 2022 |
Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc. |
|
| March 7, 2022 |
VIEMED HEALTHCARE ANNOUNCES 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES 2021 FINANCIAL RESULTS Lafayette, Louisiana (March 7, 2022) Viemed Healthcare, Inc. |
|
| March 7, 2022 |
Subsidiaries of the Registrant. EX-21.1 3 exhibit211subsidiariesofth.htm EX-21.1 EXHIBIT 21.1 List of Subsidiaries Name Jurisdiction of Formation Viemed, Inc. Delaware Home Sleep Delivered, L.L.C. Louisiana Sleep Management, L.L.C. Louisiana Viemed Clinical Services, L.L.C. Louisiana Viemed Healthcare Staffing, L.L.C. Louisiana 1 |
|
| February 17, 2022 |
VMD / Viemed Healthcare, Inc. / Hoyt Casey - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 14, 2022 |
VMD / Viemed Healthcare, Inc. / THRIVENT FINANCIAL FOR LUTHERANS Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 10, 2022 |
VMD / Viemed Healthcare, Inc. / CI INVESTMENTS INC. Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Shares - (Title of Class of Securities) 92663R105 - (CUSIP Number) December 31, 2021 - (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 3, 2022 |
CA:VMD / Viemed Healthcare Inc / BlackRock Inc. Passive Investment ca92663r1055020322.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 1) VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) BFFK5Z9 - (SEDOL Number) December 31, 2021 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| November 3, 2021 |
LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / NOVEMBER 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about VieMed Healthcare, Inc. |
|
| November 3, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 November 3, 2021 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| November 2, 2021 |
VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES THIRD QUARTER 2021 FINANCIAL RESULTS Lafayette, Louisiana (November 1, 2021) Viemed Healthcare, Inc. |
|
| November 2, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 2, 2021 |
RESTRICTED STOCK UNITS AWARD AGREEMENT THIS RESTRICTED STOCK UNITS AWARD AGREEMENT (this ?Agreement?) is made and entered into by and between Viemed Healthcare, Inc. |
|
| November 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, |
|
| November 2, 2021 |
VIEMED HEALTHCARE, INC. NON-EMPLOYEE DIRECTORS DEFERRED COMPENSATION PLAN 1.Purpose. The purpose of the Viemed Healthcare, Inc. Non-Employee Directors Deferred Compensation Plan (the ?Plan?) is to aid the Company in attracting and retaining experienced Non-Employee Directors by providing them with the opportunity to defer receipt, and thus taxation, of the shares of Stock issuable to them under th |
|
| September 16, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 September 16, 2021 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) |
|
| September 16, 2021 |
VIEMED HEALTHCARE ANNOUNCES SECOND PUBLISHED NON-INVASIVE VENTILATION STUDY VIEMED HEALTHCARE ANNOUNCES SECOND PUBLISHED NON-INVASIVE VENTILATION STUDY Lafayette, Louisiana (September 16, 2021) Viemed Healthcare, Inc. |
|
| August 6, 2021 |
LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / AUGUST 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the ?Presentation?) about Viemed Healthcare, Inc. |
|
| August 6, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 August 5, 2021 Date of Report (Date of earliest event reported) Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| August 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| August 2, 2021 |
VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES SECOND QUARTER 2021 FINANCIAL RESULTS Lafayette, Louisiana (August 2, 2021) Viemed Healthcare, Inc. |
|
| August 2, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Co |
|
| June 10, 2021 |
VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL & SPECIAL MEETING OF SHAREHOLDERS VIEMED HEALTHCARE ANNOUNCES VOTING RESULTS FROM ITS ANNUAL & SPECIAL MEETING OF SHAREHOLDERS Lafayette, Louisiana (June 10, 2021) Viemed Healthcare, Inc. |
|
| June 10, 2021 |
Number: BC 1100228 BUSINESS CORPORATIONS ACT ARTICLES of VIEMED HEALTHCARE, INC. TABLE OF CONTENTS ARTICLE 1 INTERPRETATION ............................................................................................................................. 1 ARTICLE 2 SHARES AND SHARE CERTIFICATES .......................................................................................... 2 ARTICLE 3 ISSUE |
|
| June 10, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 10, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| May 24, 2021 |
VIEMED HEALTHCARE COMMENTS ON FINAL REPORT ISSUED BY OFFICE OF INSPECTOR GENERAL VIEMED HEALTHCARE COMMENTS ON FINAL REPORT ISSUED BY OFFICE OF INSPECTOR GENERAL Lafayette, Louisiana (May 24, 2021) Viemed Healthcare, Inc. |
|
| May 24, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 24, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Comm |
|
| May 6, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 6, 2021 |
EX-99.1 2 vmddeckmay2021.htm EX-99.1 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MAY 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. (“Viemed”) is dated as of May 2021. It is information in a summary form and does not purport to be complete. The data contained herein is derived from v |
|
| May 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 3, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Commi |
|
| May 3, 2021 |
VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES FIRST QUARTER 2021 FINANCIAL RESULTS Lafayette, Louisiana (May 3, 2021) Viemed Healthcare, Inc. |
|
| May 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| April 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| April 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Definitive Proxy State |
|
| March 4, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits 8-K 1 a8-kmarch2021investordeck.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 4, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or o |
|
| March 4, 2021 |
vmddatemarch2021 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / MARCH 2021 DISCLAIMERS 2 Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. |
|
| March 3, 2021 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 3, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (Com |
|
| March 3, 2021 |
Form of Restricted Stock Units Agreement. RESTRICTED STOCK UNITS AWARD AGREEMENT THIS RESTRICTED STOCK UNITS AWARD AGREEMENT (this ?Agreement?) is made and entered into by and between Viemed Healthcare, Inc. |
|
| March 3, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ? ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-38973 Viemed Healthcare, Inc. (Exa |
|
| March 3, 2021 |
Description of Registrant's Securities. DESCRIPTION OF THE REGISTRANT?S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description sets forth certain material terms and provisions of the common shares of Viemed Healthcare, Inc. |
|
| March 3, 2021 |
Form of Award Agreement for Stock Option. VIEMED HEALTHCARE, INC. 2020 LONG TERM INCENTIVE PLAN AWARD AGREEMENT FOR A STOCK OPTION This Award Agreement for a Stock Option (?Option Agreement?) is made and entered into as of the Date of Grant set forth in the Notice of Grant of an Award of a Stock Option (?Notice of Grant?) by and between Viemed Healthcare, Inc., a corporation duly incorporated under the laws of the Province of British Colu |
|
| March 3, 2021 |
VIEMED HEALTHCARE ANNOUNCES RECORD 2020 FINANCIAL RESULTS VIEMED HEALTHCARE ANNOUNCES RECORD 2020 FINANCIAL RESULTS Lafayette, Louisiana (March 3, 2021) Viemed Healthcare, Inc. |
|
| February 12, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240. |
|
| February 12, 2021 |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| February 11, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) |
|
| February 11, 2021 |
Commonwealth Primary Care ACO and VieMed Healthcare announce an innovative chronic respiratory care and sleep management alliance VieMed’s clinically proven care model being deployed in Arizona to improve outcomes in patients with impaired respiratory function Lafayette, Louisiana (February 11, 2021) – Viemed Healthcare, Inc. |
|
| February 9, 2021 |
SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1)* Viemed Healthcare, Inc. (Name of Issuer) Common Shares (Title of Class of Securities) 92663R105 (CUSIP Number) December 31, 2020 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to |
|
| February 4, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Shares - (Title of Class of Securities) 92663R105 - (CUSIP Number) December 31, 2020 - (Date Of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh |
|
| February 2, 2021 |
ca92663r1055020221.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: ) VIEMED HEALTHCARE, INC. - (Name of Issuer) Common Stock - (Title of Class of Securities) BFFK5Z9 - (SEDOL Number) December 31, 2020 - (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant |
|
| January 7, 2021 |
VIEMED HEALTHCARE ANNOUNCES RECENT PUBLICATION OF NON-INVASIVE VENTILATION STUDY VIEMED HEALTHCARE ANNOUNCES RECENT PUBLICATION OF NON-INVASIVE VENTILATION STUDY Lafayette, Louisiana (January 7, 2021) Viemed Healthcare, Inc. |
|
| January 7, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2021 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) (C |
|
| December 21, 2020 |
VIEMED HEALTHCARE ANNOUNCES ENTRY INTO REMOTE PATIENT MONITORING SECTOR VIEMED HEALTHCARE ANNOUNCES ENTRY INTO REMOTE PATIENT MONITORING SECTOR Lafayette, Louisiana (December 21, 2020) Viemed Healthcare, Inc. |
|
| December 21, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) |
|
| November 10, 2020 |
VMD / Viemed Healthcare, Inc. / Moore Michael - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| November 10, 2020 |
VMD / Viemed Healthcare, Inc. / Hoyt Casey - SC 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. |
|
| November 9, 2020 |
VIEMED HEALTHCARE ANNOUNCES NEW INDEPENDENT BOARD MEMBER VIEMED HEALTHCARE ANNOUNCES NEW INDEPENDENT BOARD MEMBER Lafayette, Louisiana (November 9, 2020) Viemed Healthcare, Inc. |
|
| November 9, 2020 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 6, 2020 |
Regulation FD Disclosure, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 6, 2020 Viemed Healthcare, Inc. (Exact name of registrant as specified in its charter) British Columbia, Canada 001-38973 N/A (State or other jurisdiction of incorporation) ( |
|
| November 6, 2020 |
vmd-deckxnovember2020 LEADING THE HEALTHCARE INDUSTRY IN HOME RESPIRATORY CARE IR PRESENTATION / NOVEMBER 2020 DISCLAIMERS Disclaimers and Other Important Information This presentation (the “Presentation”) about Viemed Healthcare, Inc. |
